Weigao Group releases overseas regulatory update on subsidiary Weigao Orthopaedic’s disclosure to Shanghai Stock Exchange

Bulletin Express03-27

Shandong Weigao Group Medical Polymer Company Limited (Weigao Group) has issued an Overseas Regulatory Announcement pursuant to Rule 13.10B of the Hong Kong Listing Rules, notifying investors that its subsidiary, Shandong Weigao Orthopaedic Device Company Limited, has published an announcement on the Shanghai Stock Exchange’s website (search code: 688161).

The Hong Kong Exchanges and Clearing Limited and the Stock Exchange of Hong Kong Limited expressly disclaim responsibility for the contents of this notice and any losses arising from reliance on it.

The update was released on 27 March 2026 from Weihai, Shandong, and signed by Chairman Long Jing on behalf of the board. The current board of Weigao Group comprises: • Executive Directors: Long Jing, Cong Rinan, Lu Junqiang, Wang Daoming • Non-executive Directors: Chen Lin, Tang Zhengpeng • Independent Non-executive Directors: Li Guohui, Meng Hong, Li Qiang, Sun Heng

Further details of the subsidiary’s announcement can be accessed directly via the Shanghai Stock Exchange website. No additional financial figures were provided in the current notice.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1171851626?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-27 21:04","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1171851626","market":"us","top_or_hot":-1,"title":"Weigao Group releases overseas regulatory update on subsidiary Weigao Orthopaedic’s disclosure to Shanghai Stock Exchange","media":"Bulletin Express","content":"<p>Shandong Weigao Group Medical Polymer Company Limited (Weigao Group) has issued an Overseas Regulatory Announcement pursuant to Rule 13.10B of the Hong Kong Listing Rules, notifying investors that its subsidiary, Shandong Weigao Orthopaedic Device Company Limited, has published an announcement on the Shanghai Stock Exchange’s website (search code: 688161).</p>\n<p>The Hong Kong Exchanges and Clearing Limited and the Stock Exchange of Hong Kong Limited expressly disclaim responsibility for the contents of this notice and any losses arising from reliance on it.</p>\n<p>The update was released on 27 March 2026 from Weihai, Shandong, and signed by Chairman Long Jing on behalf of the board. The current board of Weigao Group comprises:\n• Executive Directors: Long Jing, Cong Rinan, Lu Junqiang, Wang Daoming  \n• Non-executive Directors: Chen Lin, Tang Zhengpeng  \n• Independent Non-executive Directors: Li Guohui, Meng Hong, Li Qiang, Sun Heng</p>\n<p>Further details of the subsidiary’s announcement can be accessed directly via the Shanghai Stock Exchange website. No additional financial figures were provided in the current notice.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Weigao Group releases overseas regulatory update on subsidiary Weigao Orthopaedic’s disclosure to Shanghai Stock Exchange</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWeigao Group releases overseas regulatory update on subsidiary Weigao Orthopaedic’s disclosure to Shanghai Stock Exchange\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-03-27 21:04</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shandong Weigao Group Medical Polymer Company Limited (Weigao Group) has issued an Overseas Regulatory Announcement pursuant to Rule 13.10B of the Hong Kong Listing Rules, notifying investors that its subsidiary, Shandong Weigao Orthopaedic Device Company Limited, has published an announcement on the Shanghai Stock Exchange’s website (search code: 688161).</p>\n<p>The Hong Kong Exchanges and Clearing Limited and the Stock Exchange of Hong Kong Limited expressly disclaim responsibility for the contents of this notice and any losses arising from reliance on it.</p>\n<p>The update was released on 27 March 2026 from Weihai, Shandong, and signed by Chairman Long Jing on behalf of the board. The current board of Weigao Group comprises:\n• Executive Directors: Long Jing, Cong Rinan, Lu Junqiang, Wang Daoming  \n• Non-executive Directors: Chen Lin, Tang Zhengpeng  \n• Independent Non-executive Directors: Li Guohui, Meng Hong, Li Qiang, Sun Heng</p>\n<p>Further details of the subsidiary’s announcement can be accessed directly via the Shanghai Stock Exchange website. No additional financial figures were provided in the current notice.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01066","symbol_name":"威高股份","start_time":0,"source_url":"","article_id":"1171851626","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1171851626","pubTimestamp":1774616653,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Shandong Weigao Group Medical Polymer Company Limited (Weigao Group) has issued an Overseas Regulatory Announcement pursuant to Rule 13.10B of the Hong Kong Listing Rules, notifying investors that...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01066":"威高股份"},"translate_title":"威高集团发布子公司威高骨科向上交所披露境外监管动态","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01066":1},"content_text":"Shandong Weigao Group Medical Polymer Company Limited (Weigao Group) has issued an Overseas Regulatory Announcement pursuant to Rule 13.10B of the Hong Kong Listing Rules, notifying investors that its subsidiary, Shandong Weigao Orthopaedic Device Company Limited, has published an announcement on the Shanghai Stock Exchange’s website (search code: 688161).\nThe Hong Kong Exchanges and Clearing Limited and the Stock Exchange of Hong Kong Limited expressly disclaim responsibility for the contents of this notice and any losses arising from reliance on it.\nThe update was released on 27 March 2026 from Weihai, Shandong, and signed by Chairman Long Jing on behalf of the board. The current board of Weigao Group comprises:\n• Executive Directors: Long Jing, Cong Rinan, Lu Junqiang, Wang Daoming  \n• Non-executive Directors: Chen Lin, Tang Zhengpeng  \n• Independent Non-executive Directors: Li Guohui, Meng Hong, Li Qiang, Sun Heng\nFurther details of the subsidiary’s announcement can be accessed directly via the Shanghai Stock Exchange website. No additional financial figures were provided in the current notice.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1171851626","isCrawlerRequest":true}